AC
ICCM icon

Armistice Capital’s IceCure Medical ICCM Stock Holding History

Armistice Capital’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$816K Buy
+90,400
New +$1.65M 0.01% 168

Other funds holding ICCM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return

Armistice Capital's ICCM Position: Q1 2026 in Review

Armistice Capital opened a new position in IceCure Medical (ICCM) in Q1 2026: 90,400 shares worth $816K. The stake represents 0.01% of the portfolio and ranks #168 among its holdings.

17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Armistice Capital held 90,400 shares of IceCure Medical worth $816K as of Q1 2026.
  • IceCure Medical was a new Armistice Capital position in Q1 2026.
  • IceCure Medical made up 0.01% of Armistice Capital's portfolio in Q1 2026, its #168 holding.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.